falseQ20001024672--12-312023-06-30

 
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 

 
F O R M 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
 
For the month of August 2023
 
Commission file number 000-28884
 
Eltek Ltd.
(Name of Registrant)
 
Sgoola Industrial Zone, Petach Tikva, Israel
(Address of Principal Executive Office)
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
 
Form 20-F ☒      Form 40-F ☐
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
 
This Form 6-K is being incorporated by reference into the Registrant’s Form S-8 Registration Statements File Nos. 333-130611 and 333-123559.

 
Eltek Ltd.
 
EXPLANATORY NOTE
 
The following exhibits are attached:
 
Signature
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
Eltek Ltd.
(Registrant)
 
By: /s/Ron Freund
Ron Freund
Chief Financial Officer
 
Dated:  August 21, 2023
 

 
0001024672eltk:DenominatedInUSDollarsMember 2022-12-31 0001024672eltk:DenominatedInUSDollarsMember 2023-06-30 0001024672eltk:DenominatedInNisMember 2022-12-31 0001024672eltk:DenominatedInNisMember 2023-06-30 0001024672eltk:DenominatedInEuroMember 2022-12-31 0001024672eltk:DenominatedInEuroMember 2023-06-30 0001024672 2023-06-30 0001024672 2022-12-31 0001024672 2023-01-01 2023-06-30 0001024672eltk:OfficersAndEmployeesMemberus-gaap:SubsequentEventMember 2023-07-01 2023-07-31 0001024672eltk:OfficersAndEmployeesMemberus-gaap:SubsequentEventMember 2023-09-30 0001024672eltk:FiveBoardMembersMemberus-gaap:SubsequentEventMember 2023-10-01 2023-10-06 0001024672eltk:OtherEmployeesMember 2023-01-01 2023-06-30 0001024672 2019-02-01 2020-10-31 0001024672 2022-07-01 2022-07-18 0001024672 2023-01-01 2023-01-31 0001024672 2023-03-31 0001024672us-gaap:RetainedEarningsMember 2023-03-31 0001024672eltk:CapitalReservesMember 2023-03-31 0001024672us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0001024672us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001024672us-gaap:CommonStockMember 2023-03-31 0001024672 2022-03-31 0001024672us-gaap:RetainedEarningsMember 2022-03-31 0001024672eltk:CapitalReservesMember 2022-03-31 0001024672us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0001024672us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001024672us-gaap:CommonStockMember 2022-03-31 0001024672us-gaap:RetainedEarningsMember 2022-12-31 0001024672eltk:CapitalReservesMember 2022-12-31 0001024672us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001024672us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001024672us-gaap:CommonStockMember 2022-12-31 0001024672 2021-12-31 0001024672us-gaap:RetainedEarningsMember 2021-12-31 0001024672eltk:CapitalReservesMember 2021-12-31 0001024672us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001024672us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001024672us-gaap:CommonStockMember 2021-12-31 0001024672us-gaap:RetainedEarningsMember 2023-06-30 0001024672eltk:CapitalReservesMember 2023-06-30 0001024672us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0001024672us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001024672us-gaap:CommonStockMember 2023-06-30 0001024672 2022-06-30 0001024672us-gaap:RetainedEarningsMember 2022-06-30 0001024672eltk:CapitalReservesMember 2022-06-30 0001024672us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-30 0001024672us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001024672us-gaap:CommonStockMember 2022-06-30 0001024672 2023-04-01 2023-06-30 0001024672us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001024672eltk:CapitalReservesMember 2023-04-01 2023-06-30 0001024672us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-01 2023-06-30 0001024672us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001024672us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001024672 2022-04-01 2022-06-30 0001024672us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001024672eltk:CapitalReservesMember 2022-04-01 2022-06-30 0001024672us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-04-01 2022-06-30 0001024672us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001024672us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001024672us-gaap:RetainedEarningsMember 2023-01-01 2023-06-30 0001024672eltk:CapitalReservesMember 2023-01-01 2023-06-30 0001024672us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-06-30 0001024672us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-06-30 0001024672us-gaap:CommonStockMember 2023-01-01 2023-06-30 0001024672 2022-01-01 2022-06-30 0001024672us-gaap:RetainedEarningsMember 2022-01-01 2022-06-30 0001024672eltk:CapitalReservesMember 2022-01-01 2022-06-30 0001024672us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-06-30 0001024672us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-06-30 0001024672us-gaap:CommonStockMember 2022-01-01 2022-06-30 0001024672eltk:CustomerAMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-06-30 0001024672eltk:CustomerAMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember 2023-04-01 2023-06-30 0001024672eltk:CustomerAMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember 2022-04-01 2022-06-30 0001024672eltk:CustomerBMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember 2022-04-01 2022-06-30 0001024672eltk:CustomerBMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember 2023-04-01 2023-06-30 0001024672eltk:CustomerBMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-06-30 0001024672country:IL 2022-04-01 2022-06-30 0001024672country:IL 2023-04-01 2023-06-30 0001024672country:IL 2023-01-01 2023-06-30 0001024672srt:NorthAmericaMember 2022-04-01 2022-06-30 0001024672srt:NorthAmericaMember 2023-04-01 2023-06-30 0001024672srt:NorthAmericaMember 2023-01-01 2023-06-30 0001024672country:NL 2022-04-01 2022-06-30 0001024672country:NL 2023-04-01 2023-06-30 0001024672country:NL 2023-01-01 2023-06-30 0001024672country:IN 2022-04-01 2022-06-30 0001024672country:IN 2023-04-01 2023-06-30 0001024672country:IN 2023-01-01 2023-06-30 0001024672eltk:RestOfWorldMember 2022-04-01 2022-06-30 0001024672eltk:RestOfWorldMember 2023-04-01 2023-06-30 0001024672eltk:RestOfWorldMember 2023-01-01 2023-06-30 0001024672eltk:CustomerAMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-06-30 0001024672eltk:CustomerBMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-06-30 0001024672country:IL 2022-01-01 2022-06-30 0001024672srt:NorthAmericaMember 2022-01-01 2022-06-30 0001024672country:NL 2022-01-01 2022-06-30 0001024672country:IN 2022-01-01 2022-06-30 0001024672eltk:RestOfWorldMember 2022-01-01 2022-06-30 0001024672eltk:ShareIncentivePlan2018Member 2023-01-01 2023-06-30 0001024672 2022-01-01 2022-12-31 0001024672eltk:ShareIncentivePlan2019Member 2023-01-01 2023-06-30 0001024672eltk:NistecMember 2023-01-01 2023-06-30 eltk:Former_Employees iso4217:ILS iso4217:ILSxbrli:shares xbrli:pure xbrli:shares iso4217:USD iso4217:USDxbrli:shares

Exhibit 99.1
 
ELTEK LTD.
 
INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
 
AS OF JUNE 30, 2023
 
U.S. Dollars in thousands
 
UNAUDITED
 
INDEX
 
 
Page
  
  
F-2 - F-3
  
F-4
  
F-5 - F-6
  
F-7 - F-8
  
F-9 - F-17
 

ELTEK LTD. AND ITS SUBSIDIARIES
 
INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS

U.S. dollars in thousands
 
         
June 30,
   
December 31,
 
   
Note
   
2023
   
2022
 
         
Unaudited
       
                   
ASSETS
                 
                   
CURRENT ASSETS:
                 
                   
Cash and cash equivalents
 
3
     
8,330
     
7,366
 
Trade receivables (net of allowance for doubtful accounts of $310 and $162 at June 30, 2023 and December 31, 2022, respectively)
         
11,383
     
10,116
 
Inventories
 
4
     
5,688
     
5,130
 
Other accounts receivable and prepaid expenses
         
1,059
     
786
 
                       
Total current assets
         
26,460
     
23,398
 
                       
LONG-TERM ASSETS:
                     
                       
Severance pay fund
         
56
     
59
 
Restricted deposit
         
-
     
202
 
Long-term tax receivables
         
857
     
899
 
Deferred tax asset, net
         
951
     
1,597
 
Operating lease right-of-use assets
         
6,742
     
7,156
 
                       
           
8,606
     
9,913
 
                       
Property and equipment, net
         
6,399
     
7,674
 
                       
Total long-term assets
         
15,005
     
17,587
 
                       
Total assets
         
41,465
     
40,985
 
 
The accompanying notes are an integral part of these consolidated financial statements.
 

F - 2


ELTEK LTD. AND ITS SUBSIDIARIES
 
INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS

U.S. dollars in thousands (except share and per share data)
 
         
June 30,
   
December 31,
 
   
Note
   
2023
   
2022
 
         
Unaudited
       
LIABILITIES AND SHAREHOLDERS' EQUITY
                 
                   
CURRENT LIABILITIES:
                 
                   
Current maturities of long-term debt
         
-
     
702
 
Trade payables
         
4,690
     
4,793
 
Other accounts payable and accrued expenses
         
6,352
     
4,133
 
Short-term operating lease liabilities
         
788
     
846
 
                       
Total current liabilities
         
11,830
     
10,474
 
                       
LONG-TERM LIABILITIES:
                     
                       
Long-term debt, excluding current maturities
         
-
     
2,768
 
Accrued severance pay
         
288
     
280
 
Long-term operating lease liabilities
         
6,058
     
6,443
 
                       
Total long-term liabilities
         
6,346
     
9,491
 
                       
COMMITMENTS AND CONTINGENT LIABILITIES
 
5
     
-
     
-
 
                       
SHAREHOLDERS' EQUITY:
 
6
                 
Share capital -
                     
Ordinary shares of NIS 3.0 par value –
Authorized: 10,000,000 shares at June 30, 2023 and December 31, 2022; Issued and outstanding: 5,907,715 shares at June 30, 2023 and 5,849,678 shares at December 31, 2022
         
5,353
     
5,305
 
Additional paid-in capital
         
23,113
     
22,862
 
Foreign currency translation adjustments
         
140
     
1,189
 
Capital reserves
         
1,681
     
1,537
 
Accumulated deficit
         
(6,998
)
   
(9,873
)
                       
Total shareholders' equity
         
23,289
     
21,020
 
                       
Total liabilities and shareholders' equity
         
41,465
     
40,985
 
 
The accompanying notes are an integral part of these consolidated financial statements.
 

F - 3


ELTEK LTD. AND ITS SUBSIDIARIES
 
INTERIM CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

U.S. dollars in thousands (except per share data)
 
 
 
Note
   
Six months ended June 30,
   
Three months ended June 30,
 
 
       
2023
   
2022
   
2023
   
2022
 
         
Unaudited
 
             
Revenues
 
7
     
22,513
     
18,844
     
11,043
     
9,089
 
Cost of revenues
         
16,546
     
15,205
     
8,091
     
7,411
 
                                       
Gross profit
         
5,967
     
3,639
     
2,952
     
1,678
 
                                       
Operating expenses:
                                     
Research and development, net
         
24
     
44
     
15
     
26
 
Selling, general and administrative
         
2,960
     
2,598
     
1,543
     
1,306
 
                                       
Operating income
         
2,983
     
997
     
1,394
     
346
 
Finance income, net
         
477
     
732
     
190
     
611
 
                                       
Income before income taxes
         
3,460
     
1,729
     
1,584
     
957
 
Taxes on income
 
8
     
585
     
344
     
271
     
204
 
                                       
Net income
         
2,875
     
1,385
     
1,313
     
753
 
 
                                     
Other comprehensive income (loss):
                                     
Foreign currency translation adjustments
         
(1,049
)
   
(2,352
)
   
(468
)
   
(1,930
)
                                       
Total comprehensive income (loss)
         
1,826
     
(967
)
   
845
     
(1,177
)
 
                                     
Basic and diluted income per ordinary share
         
0.49
     
0.24
     
0.22
     
0.13
 
 
The accompanying notes are an integral part of these consolidated financial statements.
 

F - 4


ELTEK LTD. AND ITS SUBSIDIARIES
 
INTERIM CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY

U.S. dollars in thousands (except share data)
 
               
Company's shareholders
 
   
Ordinary
shares
   
Amount
   
Additional
paid-in
capital
   
Accumulated
other
comprehensive
income (loss)
   
Capital
reserves
   
Accumulated
deficit
   
Total
 
                                           
                                           
Balance as of April 1, 2023
   
5,849,678
     
5,305
     
22,862
     
608
     
1,609
     
(8,311
)
   
22,073
 
                                                         
Share-based compensation
   
-
     
-
     
-
     
-
     
72
     
-
     
72
 
Exercise of stock options
   
58,037
     
48
     
251
     
-
     
-
     
-
     
299
 
Comprehensive income:
                                                       
Foreign currency translation adjustments
   
-
     
-
     
-
     
(468

)

   
-
     
-
     
(468
)
Net income
   
-
     
-
     
-
     
-
     
-
     
1,313
     
1,313
 
                                                         
Balance as of June 30, 2023
   
5,907,715
     
5,353
     
23,113
     
140
     
1,681
     
(6,998
)
   
23,289
 
                                                         
Balance as of April 1, 2022
   
5,849,678
     
5,305
     
22,862
     
3,294
     
1,340
     
(11,441
)
   
21,360
 
Share-based compensation
   
-
     
-
     
-
     
-
     
64
     
-
     
64
 
Comprehensive income:
                                                       
Foreign currency translation adjustments
   
-
     
-
     
-
     
(1,930

)

   
-
     
-
     
(1,930
)
Net income
   
-
     
-
     
-
     
-
     
-
     
753
     
753
 
                                                         
Balance as of June 30, 2022
   
5,849,678
     
5,305
     
22,862
     
1,364
     
1,404
     
(10,688
)
   
20,247
 
 
The accompanying notes are an integral part of these consolidated financial statements.
 

F - 5


ELTEK LTD. AND ITS SUBSIDIARIES
 
INTERIM CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY

U.S. dollars in thousands (except share data)
 
               
Company's shareholders
 
   
Ordinary
shares
   
Amount
   
Additional
paid-in
capital
   
Accumulated
other
comprehensive
income (loss)
   
Capital
reserves
   
Accumulated
deficit
   
Total
 
                                           
Balance as of January 1, 2023
   
5,849,678
     
5,305
     
22,862
     
1,189
     
1,537
     
(9,873
)
   
21,020
 
                                                         
Share-based compensation
   
-
     
-
     
-
     
-
     
144
     
-
     
144
 
Exercise of stock options
   
58,037
     
48
     
251
     
-
     
-
     
-
     
299
 
Comprehensive income:
                                                       
Foreign currency translation adjustments
   
-
     
-
     
-
     
(1,049

)

   
-
     
-
     
(1,049
)
Net income
   
-
     
-
     
-
     
-
     
-
     
2,875
     
2,875
 
                                                         
Balance as of June 30, 2023
   
5,907,715
     
5,353
     
23,113
     
140
     
1,681
     
(6,998
)
   
23,289
 
                                                         
Balance as of January 1, 2022
   
5,840,357
     
5,296
     
22,846
     
3,716
     
1,287
     
(12,073
)
   
21,072
 
Share-based compensation
   
-
     
-
     
-
     
-
     
117
     
-
     
117
 
Exercise of stock options
   
9,321
     
9
     
16
     
-
     
-
     
-
     
25
 
Comprehensive income:
                                                       
Foreign currency translation adjustments
   
-
     
-
     
-
     
(2,352

)

   
-
     
-
     
(2,352
)
Net income
   
-
     
-
     
-
     
-
     
-
     
1,385
     
1,385
 
                                                         
Balance as of June 30, 2022
   
5,849,678
     
5,305
     
22,862
     
1,364
     
1,404
     
(10,688
)
   
20,247
 
 
The accompanying notes are an integral part of these consolidated financial statements.
 

F - 6


ELTEK LTD. AND ITS SUBSIDIARIES
 
INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

U.S. dollars in thousands
 
   
Six months ended
June 30,
 
   
2023
   
2022
 
             
CASH FLOWS FROM OPERATING ACTIVITIES:
           
Net income
   
2,875
     
1,385
 
                 
Adjustments required to reconcile net income to net cash flows provided by operating activities:
               
Depreciation
   
630
     
880
 
Share-based compensation
   
144
     
117
 
Changes in deferred income tax assets, net
   
566
     
335
 
Increase (decrease) in employee severance benefits, net
   
22
     
-
 
Decrease (increase) in trade receivables, net
   
(1,784
)
   
(2,300
)
Decrease (increase) in operating lease right-of-use assets
   
575
     
145
 
Increase (decrease) in operating lease liabilities
   
(597
)
   
(149
)
Decrease (increase) in other receivables and prepaid expenses
   
(311
)
   
83
 
Decrease (increase) in inventories
   
(809
)
   
(731
)
Increase (decrease) in trade payables
   
105
     
786
 
Increase (decrease) in other liabilities and accrued expenses
   
1,477
     
302
 
                 
Net cash provided by operating activities
   
2,893
     
853
 
                 
CASH FLOWS FROM INVESTING ACTIVITIES:
               
Purchase of property and equipment
   
(711
)
   
(615
)
Insurance Proceeds
   
2,000
     
-
 
Restricted deposits
   
192
 
   
(1
)
                 
Net cash used in investing activities
   
1,481
     
(616
)
                 
CASH FLOWS FROM FINANCING ACTIVITIES:
               
Exercise of options
   
299
     
25
 
Repayment of long-term loans
   
(3,348
)
   
(258
)
Repayment of property and equipment payables
   
-
     
(7
)
                 
Net cash used in financing activities
   
(3,049
)
   
(240
)
 
The accompanying notes are an integral part of these consolidated financial statements.
 

F - 7


ELTEK LTD. AND ITS SUBSIDIARIES
 
INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (CONT.)

U.S. dollars in thousands
 
   
Six months ended
June 30,
 
   
2023
   
2022
 
             
Effect of exchange rate on cash and cash equivalents
   
(361
)
   
(1,034
)
                 
Increase (decrease) in cash and cash equivalents
   
964
     
(1,037
)
Cash and cash equivalents at the beginning of the year
   
7,366
     
9,283
 
                 
Cash and cash equivalents at end of the year
   
8,330
     
8,246
 
                 
SUPPLEMENTAL DISCLOSURES OF CASH FLOW ACTIVITIES:
               
                 
Cash paid during the period for:
               
Interest
   
81
     
30
 
 
The accompanying notes are an integral part of these consolidated financial statements.
 

F - 8


ELTEK LTD. AND ITS SUBSIDIARIES
 
NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

U.S. dollars in thousands (except share and per share data)

   
NOTE 1:-
DESCRIPTION OF BUSINESS AND GENERAL
 
  a.
General:
 
Eltek Ltd. ("the Company") was established in Israel in 1970, and its ordinary shares have been publicly traded on the NASDAQ Capital Market ("NASDAQ") since 1997. Eltek Ltd. and its subsidiaries (Eltek USA Inc. and Eltek Europe GmbH) are collectively referred to as "the Company". As of June 30, 2023, Eltek Europe GmbH is inactive.
 
The Company manufactures, markets and sells custom made printed circuit boards ("PCBs") including, high density interconnect, flex-rigid and multi-layered boards. The principal markets of the Company are in Israel, Europe, North America and India.
 
The Company markets its products mainly to the medical device, defense and aerospace, industrial, telecom and networking equipment industries, as well as to contract electronic manufacturers.
 
The Company is controlled by Nistec Golan Ltd ("Nistec Golan"). Nistec Golan is controlled indirectly by Mr. Yitzhak Nissan, who owns, indirectly through Nistec Holdings Ltd., all of the shares of Nistec Golan (Nistec Holdings Ltd. and/or any of its subsidiaries are referred to as "Nistec").
 
  b.
Financial covenants:
 
The Company is required to maintain certain financial covenants, including: (i) adjusted shareholders' equity (excluding certain intangible and other assets) equal to the greater of $4.5 million or 17% of its consolidated total assets; and (ii) a debt service ratio of 1.5. Debt service ratio is defined as the ratio of EBITDA to current maturities of long-term debt plus interest expenses. Compliance with the financial covenants is measured annually based on the Company’s annual audited financial statements. As of June 30, 2023 and December 31, 2022, the Company was in compliance with these covenants.
 
  c.
Business risks and condition:
 
The Company’s business is subject to numerous risks including, but not limited to, the impact of currency exchange rates (mainly NIS/US$), the Company's ability to implement its sales and manufacturing plans, the impact of competition from other companies, the Company's ability to receive regulatory clearance or approval to market its products, changes in regulatory environment, domestic and global economic conditions and industry conditions, and compliance with environmental laws and regulations.
 
As of June 30, 2023, the Company's working capital amounted to $14.6 million, and its accumulated deficit amounted to approximately $7.0 million. The Company's liquidity position, as well as its operating performance, may be negatively affected by other financial and business factors, many of which are beyond its control.

 

F - 9

ELTEK LTD. AND ITS SUBSIDIARIES
 
NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

U.S. dollars in thousands (except share and per share data)

 

NOTE 2:-
CONSOLIDATED UNAUDITED FINANCIAL STATEMENTS
 
 
The accompanying consolidated unaudited financial statements have been prepared in a condensed format and include the consolidated unaudited financial operations of the Company as of June 30, 2023 and for the six month periods then ended, in accordance with U.S. GAAP, relating to the preparation of financial statements for interim periods.
 
Accordingly, the accompanying consolidated unaudited financial statements do not include all the information and footnotes required by generally accepted accounting principles for a complete set of financial statements. These consolidated unaudited financial statements should be read in conjunction with the audited financial statements and the accompanying notes of the Company for the year ended December 31, 2022 that are included in the Company's Annual Report on Form 20-F, filed with the Securities and Exchange Commission on March 29, 2023 (the "Annual Report"). In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the six months ended June 30, 2023, are not necessarily indicative of the results that may be expected for the year ended December 31, 2023.

 

NOTE 3:-
CASH AND CASH EQUIVALENTS
 
   
June 30,
   
December 31,
 
   
2023
   
2022
 
   
Unaudited
       
             
Denominated in U.S. dollars
   
3,235
     
2,334
 
Denominated in NIS
   
3,498
     
2,620
 
Denominated in Euro
   
1,597
     
2,412
 
                 
     
8,330
     
7,366
 

 

NOTE 4:-
INVENTORIES
   
   
June 30,
   
December 31,
 
   
2023
   
2022
 
   
Unaudited
       
             
Raw materials
   
2,247
     
2,201
 
Work-in-progress
   
2,985
     
2,468
 
Finished goods
   
456
     
461
 
                 
     
5,688
     
5,130
 
 
 
During the periods ended June 30, 2023 and June 30, 2022, the Company recorded inventory write-offs in the amounts of $192 and $126, respectively. Such write-offs were included in cost of revenues.

 

F - 10

ELTEK LTD. AND ITS SUBSIDIARIES
 
NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

U.S. dollars in thousands (except share and per share data)

 

NOTE 5:-
COMMITMENTS AND CONTINGENT LIABILITIES
 
  a.
Pledges:
 
  1.
The Company has pledged certain items of its equipment and the rights to any insurance claims on such items to secure its debts to banks, as well as placed floating liens on all of its remaining assets in favor of the banks.
 
  2.
The Company has also pledged machines to secure its indebtedness to certain suppliers that provided financing for such equipment.
 
  b.
Indemnification agreement:
 
The Company entered into indemnification agreements with each of its directors and officers and undertook to enter into the same agreement with future directors and officers. Such indemnification amount will not exceed: (i) the value of 25% of the Company’s net equity according to the audited or reviewed financial statement known at the time the request for indemnification was submitted; or (ii) $3,000,000, whichever is greater.
     

F - 11

ELTEK LTD. AND ITS SUBSIDIARIES
 
NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

U.S. dollars in thousands (except share and per share data)

 

NOTE 5:-
COMMITMENTS AND CONTINGENT LIABILITIES (CONT.)
   
   
The Israeli Companies Law provides that an Israeli company cannot exculpate an officer holder from liability with respect to a breach of his or her duty of loyalty. If permitted by its articles of association, a company may exculpate in advance an officer from his or her liability to the company, in whole or in part, with respect to a breach of his or her duty of care. However, a company may not exculpate in advance a director from his or her liability to the company with respect to a breach of his duty of care with respect to distributions.
 
The Company's articles of association allow it to exculpate any officer holder from his or her liability for breach of duty of care, to the maximum extent permitted by law, before or after the occurrence giving rise to such liability.
 
  c.
Contingent Liabilities:
 
Environmental Related Matters
 
In March 2019, representatives of the Ministry of Environmental Protection inspected the Company's premises and issued a warning related to an alleged breach of the Clean Air Law and a warning related to the Hazardous Materials Law (1993). On July 18, 2022, the Company received a notification from the Ministry of Environmental Protection about its intention to impose a penalty of approximately $0.1 million for an alleged breach of the Hazardous Materials Law (1993). The Company paid the penalty during 2023.
 
In January 2023, the Company received a notification from the Ministry of Environmental Protection about its intention to impose a penalty of approximately $0.6 million for an alleged breach of the Clean Air Law during the years 2019-2020. The Company has filed a request to reduce the amount of the penalty in accordance with the provisions of the Clean Air Law. In August 2023, the Ministry of Environmental Protection notified the Company that it has rejected the Company's request. The Company recorded a provision in the total amount of the penalty. The Company is considering filing an administrative appeal in regard to the Ministry of Environmental Protection decision.
 

F - 12

ELTEK LTD. AND ITS SUBSIDIARIES
 
NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

U.S. dollars in thousands (except share and per share data)

 

NOTE 5:-
COMMITMENTS AND CONTINGENT LIABILITIES (CONT.)
   
   
Employee related matters
 
In May 2008, June 2019 and November 2019, lawsuits were filed by three employees alleging that they had suffered personal injuries during their employment and they are seeking aggregate financial compensation of approximately $ 121 for past damages and additional amounts for future lost income, pain and suffering as the court may determine.
 
In January 2011 and December 2019, five additional employees notified the Company that they allegedly suffered personal injuries during their employment with the Company. Of these five employees, two are seeking compensation of $1.7 million and the others did not state their claim amount.
 
The above-mentioned claims were submitted to the Company’s insurance company, which informed the Company that it is reviewing the statements of claim without prejudicing its rights to deny coverage.
 
During the period February 2019 through October 2020, two former employees filed lawsuits seeking additional payments in connection with their employment with the Company and subsequent termination. The aggregate amount claimed in the two lawsuits is approximately $345. The Company recorded a provision according to its legal advisor's opinion.

 

NOTE 6:-
SHAREHOLDERS' EQUITY
 
   
Stock Option Plan:
 
The Company’s 2018 Share Incentive Plan (the "Plan") authorizes the grant of options to purchase shares and restricted shares units (“RSUs”) to officers, employees, directors and consultants of the Company and its subsidiaries. Awards granted under the Plan to participants in various jurisdictions may be subject to specific terms and conditions for such grants as may be approved by the Company’s board from time to time.
 
Each option granted under the Plan is exercisable for a period of ten years from the date of the grant of the option or the expiration dates of the option plan. The options primarily vest gradually over four years of employment.
 
As of June 30, 2023 options to purchase 337,134 ordinary shares were outstanding under the Plan, exercisable at an average exercise price of $5.07 per share. The share-based compensation expense related to employees' equity-based awards, recognized during the six months ended June 30, 2023 and 2022 was $144 and $117, respectively
     

F - 13

ELTEK LTD. AND ITS SUBSIDIARIES
 
NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

U.S. dollars in thousands (except share and per share data)

 

NOTE 6:-
SHAREHOLDERS' EQUITY (CONT.)
   
   
A summary of employee option activity under the Plan as of June 30, 2023 and changes during the six months period ended June 30, 2023 are as follows:
 
   
Number of
options
   
Weighted-average exercise
price
   
Weighted- average remaining contractual life
(in months)
   
Aggregate intrinsic
value
(in thousands)
 
                         
Outstanding at January 1, 2023
   
395,171
     
5.25
     
95
     
1
 
Exercised
   
58,037
     
5.15
     
-
     
-
 
Forfeited
   
-
     
-
     
-
     
-
 
                                 
Outstanding at June 30, 2023
   
337,134
     
5.07
     
91
     
1,442
 
                                 
Exercisable at June 30, 2023
   
193,046
     
4.90
     
86
     
859
 
 
   
The aggregate intrinsic value in the table above represents the total intrinsic value (the difference between the Company's closing share price on the last trading day of the second quarter of fiscal 2023 and the exercise price, multiplied by the number of in-the-money options). This amount changes based on the fair market value of the Company's share. As of June 30, 2023, there was approximately $527 of unrecognized compensation costs related to non-vested share-based compensation arrangements granted under the Company's share option plans. This cost is expected to be recognized over a period of up to 4 years.

 

NOTE 7:-
ENTITY WIDE DISCLOSURES
 
  a.
Customers who accounted for over 10% of the total consolidated revenues:
 
   
Six months ended
June 30,
   
Three months ended
June 30,
 
   
2023
   
2022
   
2023
   
2022
 
   
Unaudited
 
                         
Customer A - sales of manufactured products
   
14.4
%
   
20.2
%
   
13.5
%
   
17.9
%
Customer B - Sales of manufactured products
   
11.0
%
   
9.8
%
   
11.9
%
   
9.3
%
 
  b.
Revenues by geographic areas:
 
   
Six months ended
June 30,
   
Three months ended
June 30,
 
   
2023
   
2022
   
2023
   
2022
 
   
Unaudited
 
                         
Israel
   
11,548
     
10,808
     
6,332
     
5,314
 
North America
   
2,911
     
3,708
     
1,826
     
1,773
 
 Netherlands
   
2,884
     
1,402
     
1,187
     
618
 
India
   
3,222
     
1,366
     
908
     
752
 
Others
   
1,948
     
1,560
     
790
     
632
 
                                 
     
22,513
     
18,844
     
11,043
     
9,089
 

 

F - 14

ELTEK LTD. AND ITS SUBSIDIARIES
 
NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

U.S. dollars in thousands (except share and per share data)

 

NOTE 8:-
TAXES ON INCOME
 
  a.
Deferred tax assets and liabilities:
 
The Company has net operating loss carryforwards for tax purposes of approximately $10.4 million, which may be carried forward indefinitely for which deferred tax assets was created.
 
  b.
Reconciliation of the theoretical income tax expense to the actual income tax expense:
 
For the six months period ended June 30, 2023 and 2022 the main differences between the theoretical tax expenses (statutory tax rate of 23%) and the actual tax expenses are tax benefit arising from "Preferred enterprises" and non-deductible items and others.
NOTE 9:-
RELATED PARTY BALANCES AND TRANSACTIONS
 
 
Nistec, the controlling shareholder of the Company, is also a customer of the Company. The Company sells products to Nistec, pays management fees to Nistec, purchases certain services from Nistec and shares certain expenses with Nistec, for services that it acquires jointly with Nistec. The Company's transactions with Nistec were carried out on an arm's-length basis.
 
  a.
Balances with related parties:
 
   
Six months ended
June 30,
   
Year ended
December 31,
 
   
2023
   
2022
 
   
Unaudited
       
             
Trade accounts receivable
   
190
     
151
 
Trade accounts payable
   
277
     
30
 
 
  b.
Transactions with related parties:
 
   
Six months ended
June 30,
   
Three months ended
June 30,
 
   
2023
   
2022
   
2023
   
2022
 
   
Unaudited
 
                         
Revenues
   
419
     
260
     
182
     
82
 
Purchases, selling, general and administrative expenses
   
365
     
263
     
288
     
78
 
 

F - 15

ELTEK LTD. AND ITS SUBSIDIARIES
 
NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

U.S. dollars in thousands (except share and per share data)

 

NOTE 9:-
RELATED PARTY BALANCES AND TRANSACTIONS (CONT.)
   
   
PCB purchases by Nistec - Nistec purchases PCBs from the Company solely to provide assembled boards to its customers. The Company sells to Nistec based on its standard pricing, which may be subject to a discount of up to ten percent (10%). Should the order be for PCBs imported by the Company, the quote reflects the actual price of such PCBs, plus a mark-up of at least twenty percent (20%). Should the order be for PCBs from excess inventory of an original order, the quote will reflect the standard price of such PCBs, with a discount of up to fifty percent (50%) of the price actually paid for such PCBs in the original order (the “Excess Inventory Discount”). The Excess Inventory Discount will apply only to orders from excess inventory of the first original order of a specific PCB (i.e., should a second order of a specific PCBs generate any excess inventory, and Nistec would like to purchase such excess, the Excess Inventory Discount will not be applied to such purchase).
 
Soldering and assembly services - The Company may acquire soldering services and/or purchase services from Nistec. Nistec’s pricing for its soldering services will be its standard pricing (the “Pricing”), less a five percent (5%) discount. Nistec may charge for Purchasing Services in accordance with the actual costs of the orders, plus a fourteen and a quarter (14.25%) commission, which reflects a five percent (5%) discount, as compared to the commission charged to third parties by Nistec for similar services. Prices of services not included in the Pricing will be negotiated by the parties in good faith (without participation of Mr. Nissan, the Company's controlling shareholder and CEO, or any of his relatives). Nistec standard procedures govern manufacturer warranties and restrictions regarding defective assembled products. In addition to requesting Nistec to provide the Company with a quote for soldering and assembly services, in the event that the Company requires design and/or design services for production of PCBs, it may ask Nistec to provide it with a quote for such services. Nistec may charge for design and/or design services in accordance with its standard pricing for such services, less a five percent (5%) discount. The Company’s purchases of services under the Soldering, Assembly and Design Services Procedure may not exceed NIS 300 per annum.
 
Managements fees - In September 2019, the Company's Audit Committee, Compensation Committee and Board of Directors, as applicable, approved the terms of the amended Management Agreement. This amended Management Agreement was approved by the Company's shareholders in the annual general meeting, held on December 5, 2019. Nistec is entitled to a monthly management fee of NIS 90 ($28).
 
Subject to Company’s reimbursement policy approved by the Audit Committee on May 15, 2016, Mr. Nissan receives reimbursement of travel expenses (other than food and beverage expenses) while traveling internationally on behalf of the Company, provided that such reimbursement will not exceed an aggregate amount of NIS 10,000 ($2,700) per calendar quarter. Mr. Nissan is reimbursed for food and beverage expenses while traveling internationally on behalf of the Company, against receipts, in accordance with the Israeli Income Tax Regulations (Deduction of Certain Expenses) 1972.
     

F - 16

ELTEK LTD. AND ITS SUBSIDIARIES
 
NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

U.S. dollars in thousands (except share and per share data)

 

NOTE 9:-
RELATED PARTY BALANCES AND TRANSACTIONS (CONT.)
   
   
In addition, the Company's shareholders in the annual general meetings held on December 5, 2019, October 29, 2020 and August 31, 2022 approved the following:
 
  a.
The extension of the Directors and Officers Indemnity Agreement with Mr. Yitzhak Nissan.
  b.
The extension of the Exculpation Letter for an additional three (3) year period
  c.
The application of the Company’s directors and officers' liability insurance policy with respect to Mr. Yitzhak Nissan
  d.
The revised terms of employment of Yitzhak Nissan's daughter who is employed by the Company as a special project manager.

 

NOTE 10:-
SUBSEQUENT EVENTS
 
   
Subsequent to the balance sheet date, the Company's Board of Directors approved the grant of 117,000 options to officers and employees of the Company. The options are in accordance with the Company's 2018 plan and have an exercise price of $9.11 per share. 33,000 options are subjected to the approval of shareholders at our Annual General Meeting to be held during September 2023.
 
In addition, the Board has approved grants of 10,000 options to each of its five Board members. The grants will be effective as of October 6, 2023, and are subject to the approval of shareholders at our Annual General Meeting to be held during September 2023. The exercise price will be determined based on the average price of the Company's shares during the 30-day period prior to October 6, 2023. The options are in accordance with the Company's 2018 option plan.

 

 

F - 17



Exhibit 99.2
 
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
 
The discussion and analysis which follows contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934 which reflect our current views with respect to future events and financial results. These include statements regarding our earnings, projected growth and forecasts, and similar matters which are not historical facts. We remind shareholders that forward-looking statements are merely predictions and therefore are inherently subject to uncertainties and other factors which could cause the actual future events or results to differ materially from those described in the forward-looking statements.
 
The interim condensed consolidated financial statements appearing elsewhere in this report should be read in conjunction with the audited consolidated financial statements and notes thereto included in our Annual Report on Form 20-F for the year ended December 31, 2022. The results of operations for the six months ended June 30, 2023, are not necessarily indicative of the operating results for the full fiscal year.
 
Overview
 
We manufacture, market and sell technologically advanced custom-made printed circuit boards, or PCBs, including high density interconnect, or HDI, flex-rigid and rigid, with high layer count boards.  Our principal customers include manufacturers of defense and aerospace, medical, industrial, telecom and networking equipment, as well as contract electronic manufacturers.  PCBs are constructed from a variety of base raw materials.  PCBs can be double-sided or multi-layered and made of rigid, flexible, flex-rigid or high-frequency materials.  In essence, they are platforms that conduct electrical signals among active and passive microelectronics components, microprocessors, memories, resistors and capacitors.  Photolithographic type processes transfer the images of the electrical circuit onto the layers, and chemical processes etch these lines on the boards. Our focus is on short run quick-turnaround, prototype, pre-production and low to medium volume runs of high-end PCB products for high growth, advanced electronics applications, mainly flex-rigid PCBs. We also act as an agent for the importation of PCBs from Southeast Asia when customers require high volume production runs, although such activity was less material in recent years.

Critical Accounting Estimates
 
The preparation of our consolidated financial statements and other financial information requires our management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. We evaluate on an on-going basis these estimates, mainly related to inventory, deferred tax assets and share-based compensation expenses.

We base our estimates on our experience and on various assumptions that we believe are reasonable under the circumstances. The results of our estimates form the basis for our management’s judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.

We believe the following critical accounting policies affect our more significant judgments and estimates used in the preparation of the financial information:

Inventory
 
We are required to state our inventories at the lower of cost or net realizable value.  Cost is determined on the weighted average basis for raw materials.  For work in progress and finished goods, the cost is determined based on calculation of accumulated actual direct and indirect costs. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation.

We periodically evaluate the inventory quantities on hand relative to historical and projected sales volumes, current and historical selling prices and contractual obligations to maintain certain levels of parts. Based on these evaluations, inventory write-offs are provided to cover risks arising from slow-moving items, discontinued products, excess inventories, market prices lower than cost and adjusted revenue forecasts. Any write-off is recognized in our consolidated statements of income as cost of revenues. In addition, if required, we record a liability for firm non-cancelable and unconditional purchase commitments with contract manufacturers for quantities in excess of our forecast of future demand consistent with our valuation of excess and obsolete inventory.

The process for evaluating these write-offs often requires us to make subjective judgments and estimates concerning future sales potential at which such inventory will be sold in the normal course of business. Incorrect estimates of future sales potential may cause actual results to differ from the estimates at the time such inventory is disposed of or sold. Given the significant assumptions required and the possibility that actual conditions will differ, we consider the valuations to be a critical accounting estimate.


Explanation of Key Income Statement Items
 
Revenues. Our revenues are mainly derived from sales of PCBs, including high density interconnect, flex-rigid and multi-layered boards. The principal markets of the Company are in Israel, Europe, India and North America.
 
Cost of Revenues. Cost of revenues consists primarily of salaries, raw materials, subcontractor expenses, related depreciation costs, inventories write-downs and overhead allocated to cost of revenues activities.
 
Selling, General and Administrative ExpensesSelling, general and administrative expenses consist primarily of salaries and related expenses for executive and for selling, and marketing personnel, marketing activities, accounting, legal, administrative personnel, professional fees, provisions for doubtful accounts and other general corporate expenses.
 
Financial Expenses, Net. Financial expenses consist of interest and bank expenses, interest on loans, and currency re-measurement losses. Financial income consists of interest on cash and cash equivalent balances and currency re-measurement gains.

Results of Operations
 
Revenues. Our revenues for the six months ended June 30, 2023, were $22.5 million as compared to $18.9 million for the six months ended June 30, 2022, an increase of $3.6 million, or 19%. The increase in revenues is primarily attributable to the increased demand for our products mainly due to the shift back of PCB manufacturing to Western countries and increased demand in the defense and aerospace segments.
 
Cost of Revenues. Cost of revenues increased by 8.8% to $16.5 million for the six months ended June 30, 2023 from $15.2 million for the six months ended June 30, 2022. The increase in our cost of revenues is attributable to the 19% increase in revenues.
 
Gross Profit. Our gross profit increased to $6.0 million or 26.5% for the six months ended June 30, 2023 from $3.6 million, or 19.3% for the six months ended June 30, 2022. The increase in our gross profit and gross margin in 2023 was mainly attributable to the increase in revenues and the stable fixed expenses component included in cost of goods sold.
 
Our operating expenses were $3.0 million for the six months ended June 30, 2023 as compared to $2.6 million for the six months ended June 30, 2022. Operating expenses in the 2023 period include a one-time expense in the amount of $0.35 million in regard to a penalty for an alleged breach of the Clean Air Law during the years 2019-2020.
 
Financial Expenses, Net. We had net financial income of $0.5 million in first six months of 2023 compared to net income of $0.7 million in the first six months of 2022. The decrease in financial income is primarily attributable to the rate of devaluation of the NIS exchange rate against the US Dollar and its impact on our outstanding Dollar denominated balances.

Net Profit. Our net profit for first six months of 2023 was $2.9 million compared to net profit of $1.4 million in the first six months of 2022.

 
Liquidity and Capital Resources
 
Historically, we have financed our operations through cash generated by operations, shareholder loans, long-term and short-term bank loans, borrowings under available credit facilities and the proceeds from our initial public offering in 1997 and rights offerings in 2019 and 2020.
 
As of June 30, 2023, our cash position (cash and cash equivalents) totaled $8.3 million compared to $7.4 million in cash and cash equivalents as of December 31, 2022. As of June 30, 2023, we had working capital of $14.6 million as compared to working capital of $12.9 million as of December 31, 2022.

During the first six months of 2023 we repaid all of our long-term loans (including current maturities) from banks. As of June 30, 2023, we had revolving lines of credit aggregating NIS 8.7 million ($2.4 million) with our banks, none of which was utilized as of such date. As of June 30, 2023, we were in compliance with our banks' covenants. All of our assets are pledged as security for our liabilities to our banks, whose consents are required for any future pledge of such assets.

Net cash provided by operating activities for the first six months of 2023 was $2.9 million as compared to $0.9 million during the first six months of 2022. This was primarily due to the net profit of $2.9 million incurred during this period and non-cash expenses in the amount of $1.3 which were offset mainly by an increase in trade receivables and inventories.
 
Net cash provided by investing activities during the first six months of 2023 was $1.5 million as compared to net cash used in investing activities of $0.6 million during the first six months of 2022. This was primarily due to proceeds from insurance in the amount of $2 million which were received during the first six months of 2023.
 
Net cash used in financing activities during the first six months of 2023 was $3.0 million, mainly attributable to repayment of long-term debt, compared to cash used in financing activities of $0.2 million during the first six months of 2022.
 
Our working capital requirements and cash flow provided by our operating and financing activities are likely to vary from quarter to quarter, depending on the following factors: (i) the timing of orders and deliveries; (ii) net profit in the period; (iii) the purchase of new equipment; (iv) the build‑up of inventories; (v) the payment terms offered to our customers; (vi) the payment terms offered by our suppliers; (vii) the repayment of existing lines of credit and loans; and (vii) approval of the current or additional lines of credit and long-term loans from banks.

To the extent that the funds generated from our operations and our existing capital resources are insufficient to fund our operating, financial and capital investment requirements, we will need to raise additional funds through public or private financing or other sources.  Additional financing may not be available on commercially reasonable terms, if at all.  If adequate funds are not available on terms acceptable to us, we may be required to delay, scale back or eliminate certain aspects of our operations, and our business, financial condition and results of operations would be materially adversely affected.

Corporate Tax Rate
 
The corporate tax in Israel, as of June 30, 2023, is 23%. According to the Law for the Encouragement of Capital Investments and our Preferred Enterprise status, our applicable tax rate is 16%.
 
Impact of Currency Fluctuation and of Inflation
 
A significant portion of the cost of our Israeli operations, primarily personnel and facility-related, is incurred in NIS. Therefore, our NIS related costs, as expressed in Dollars, are influenced by the exchange rate between the Dollar and the NIS. In addition, if the rate of inflation in Israel will exceed the rate of devaluation of the NIS in relation to the Dollar, or if the timing of such devaluations were to lag considerably behind inflation, our cost as expressed in Dollars may increase. NIS linked balance sheet items may also create foreign exchange gains or losses, depending upon the relative Dollar values of the NIS at the beginning and end of the reporting period, affecting our net income and earnings per share. Although we may use hedging techniques, we may not be able to eliminate the effects of currency fluctuations. Therefore, exchange rate fluctuations could have a material adverse impact on our operating results and share price.


v3.23.2
Document And Entity Information
6 Months Ended
Jun. 30, 2023
Entity Registrant Name Eltek Ltd.
Entity Central Index Key 0001024672
Amendment Flag false
Document Type 6-K
Current Fiscal Year End Date --12-31
Document Period End Date Jun. 30, 2023
Document Fiscal Year Focus 2023
Document Fiscal Period Focus Q2
Entity File Number 000-28884
Entity Address, Address Line One Sgoola Industrial Zone
Entity Address, City or Town Petach Tikva
Entity Address, Country IL
v3.23.2
INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
CURRENT ASSETS:    
Cash and cash equivalents $ 8,330 $ 7,366
Trade receivables (net of allowance for doubtful accounts of $310 and $162 at June 30, 2023 and December 31, 2022, respectively) 11,383 10,116
Inventories 5,688 5,130
Other accounts receivable and prepaid expenses 1,059 786
Total current assets 26,460 23,398
LONG-TERM ASSETS:    
Severance pay fund 56 59
Restricted deposit 0 202
Long-term tax receivables 857 899
Deferred tax asset, net 951 1,597
Operating lease right-of-use assets 6,742 7,156
Total other assets 8,606 9,913
Property and equipment, net 6,399 7,674
Total long-term assets 15,005 17,587
Total assets 41,465 40,985
CURRENT LIABILITIES:    
Current maturities of long-term debt 0 702
Trade payables 4,690 4,793
Other accounts payable and accrued expenses 6,352 4,133
Short-term operating lease liabilities 788 846
Total current liabilities 11,830 10,474
LONG-TERM LIABILITIES:    
Long-term debt, excluding current maturities 0 2,768
Accrued severance pay 288 280
Long-term operating lease liabilities 6,058 6,443
Total long-term liabilities 6,346 9,491
COMMITMENTS AND CONTINGENT LIABILITIES 0 0
SHAREHOLDERS' EQUITY:    
Ordinary shares of NIS 3.0 par value – Authorized: 10,000,000 shares at June 30, 2023 and December 31, 2022; Issued and outstanding: 5,907,715 shares at June 30, 2023 and 5,849,678 shares at December 31, 2022 5,353 5,305
Additional paid-in capital 23,113 22,862
Foreign currency translation adjustments 140 1,189
Capital reserves 1,681 1,537
Accumulated deficit (6,998) (9,873)
Total shareholders' equity 23,289 21,020
Total liabilities and shareholders' equity $ 41,465 $ 40,985
v3.23.2
INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)
$ in Thousands
Jun. 30, 2023
₪ / shares
Jun. 30, 2023
USD ($)
shares
Dec. 31, 2022
₪ / shares
Dec. 31, 2022
USD ($)
shares
Statement of Financial Position [Abstract]        
Allowance for doubtful accounts | $   $ 310   $ 162
Ordinary shares, par value | ₪ / shares ₪ 3   ₪ 3  
Ordinary shares, shares authorized   10,000,000   10,000,000
Ordinary shares, shares issued   5,907,715   5,849,678
Ordinary shares, shares outstanding   5,907,715   5,849,678
v3.23.2
INTERIM CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Income Statement [Abstract]        
Revenues $ 11,043 $ 9,089 $ 22,513 $ 18,844
Cost of revenues 8,091 7,411 16,546 15,205
Gross profit 2,952 1,678 5,967 3,639
Operating expenses:        
Research and development, net 15 26 24 44
Selling, general and administrative 1,543 1,306 2,960 2,598
Operating income 1,394 346 2,983 997
Finance income, net 190 611 477 732
Income before income taxes 1,584 957 3,460 1,729
Taxes on income 271 204 585 344
Net income 1,313 753 2,875 1,385
Other comprehensive income (loss):        
Foreign currency translation adjustments (468) (1,930) (1,049) (2,352)
Total comprehensive income (loss) $ 845 $ (1,177) $ 1,826 $ (967)
Basic income per ordinary share $ 0.22 $ 0.13 $ 0.49 $ 0.24
Diluted income per ordinary share $ 0.22 $ 0.13 $ 0.49 $ 0.24
v3.23.2
INTERIM CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Ordinary shares [Member]
Additional paid-in capital [Member]
Accumulated other comprehensive income [Member]
Capital reserves [Member]
Accumulated deficit [Member]
Total
Balance at Dec. 31, 2021 $ 5,296 $ 22,846 $ 3,716 $ 1,287 $ (12,073) $ 21,072
Balance, shares at Dec. 31, 2021 5,840,357          
Share-based compensation $ 0 0 0 117 0 117
Exercise of stock options $ 9 16 0 0 0 25
Exercise of stock options, shares 9,321          
Comprehensive income:            
Foreign currency translation adjustments $ 0 0 (2,352) 0 0 (2,352)
Net income 0 0 0 0 1,385 1,385
Balance at Jun. 30, 2022 $ 5,305 22,862 1,364 1,404 (10,688) 20,247
Balance, shares at Jun. 30, 2022 5,849,678          
Balance at Mar. 31, 2022 $ 5,305 22,862 3,294 1,340 (11,441) 21,360
Balance, shares at Mar. 31, 2022 5,849,678          
Share-based compensation $ 0 0 0 64 0 64
Comprehensive income:            
Foreign currency translation adjustments 0 0 (1,930) 0 0 (1,930)
Net income 0 0 0 0 753 753
Balance at Jun. 30, 2022 $ 5,305 22,862 1,364 1,404 (10,688) 20,247
Balance, shares at Jun. 30, 2022 5,849,678          
Balance at Dec. 31, 2022 $ 5,305 22,862 1,189 1,537 (9,873) $ 21,020
Balance, shares at Dec. 31, 2022 5,849,678         5,849,678
Share-based compensation $ 0 0 0 144 0 $ 144
Exercise of stock options $ 48 251 0 0 0 $ 299
Exercise of stock options, shares 58,037         58,037
Comprehensive income:            
Foreign currency translation adjustments $ 0 0 (1,049) 0 0 $ (1,049)
Net income 0 0 0 0 2,875 2,875
Balance at Jun. 30, 2023 $ 5,353 23,113 140 1,681 (6,998) $ 23,289
Balance, shares at Jun. 30, 2023 5,907,715         5,907,715
Balance at Mar. 31, 2023 $ 5,305 22,862 608 1,609 (8,311) $ 22,073
Balance, shares at Mar. 31, 2023 5,849,678          
Share-based compensation $ 0 0 0 72 0 72
Exercise of stock options $ 48 251 0 0 0 299
Exercise of stock options, shares 58,037          
Comprehensive income:            
Foreign currency translation adjustments $ 0 0 (468) 0 0 (468)
Net income 0 0 0 0 1,313 1,313
Balance at Jun. 30, 2023 $ 5,353 $ 23,113 $ 140 $ 1,681 $ (6,998) $ 23,289
Balance, shares at Jun. 30, 2023 5,907,715         5,907,715
v3.23.2
INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net income $ 2,875 $ 1,385
Adjustments required to reconcile net income to net cash flows provided by operating activities:    
Depreciation 630 880
Share-based compensation 144 117
Changes in deferred income tax assets, net 566 335
Increase (decrease) in employee severance benefits, net 22 0
Decrease (increase) in trade receivables, net (1,784) (2,300)
Decrease (increase) in operating lease right-of-use assets 575 145
Increase (decrease) in operating lease liabilities (597) (149)
Decrease (increase) in other receivables and prepaid expenses (311) 83
Decrease (increase) in inventories (809) (731)
Increase (decrease) in trade payables 105 786
Increase (decrease) in other liabilities and accrued expenses 1,477 302
Net cash provided by operating activities 2,893 853
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchase of property and equipment (711) (615)
Insurance Proceeds 2,000 0
Restricted deposits 192 (1)
Net cash used in investing activities 1,481 (616)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Exercise of options 299 25
Repayment of long-term loans (3,348) (258)
Repayment of property and equipment payables 0 (7)
Net cash provided by (used in) financing activities (3,049) (240)
Effect of exchange rate on cash and cash equivalents (361) (1,034)
Increase (decrease) in cash and cash equivalents 964 (1,037)
Cash and cash equivalents at the beginning of the year 7,366 9,283
Cash and cash equivalents at end of the year 8,330 8,246
SUPPLEMENTAL DISCLOSURES OF CASH FLOW ACTIVITIES:    
Cash paid during the period for: Interest $ 81 $ 30
v3.23.2
DESCRIPTION OF BUSINESS AND GENERAL
6 Months Ended
Jun. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
DESCRIPTION OF BUSINESS AND GENERAL
   
NOTE 1:-
DESCRIPTION OF BUSINESS AND GENERAL
 
  a.
General:
 
Eltek Ltd. ("the Company") was established in Israel in 1970, and its ordinary shares have been publicly traded on the NASDAQ Capital Market ("NASDAQ") since 1997. Eltek Ltd. and its subsidiaries (Eltek USA Inc. and Eltek Europe GmbH) are collectively referred to as "the Company". As of June 30, 2023, Eltek Europe GmbH is inactive.
 
The Company manufactures, markets and sells custom made printed circuit boards ("PCBs") including, high density interconnect, flex-rigid and multi-layered boards. The principal markets of the Company are in Israel, Europe, North America and India.
 
The Company markets its products mainly to the medical device, defense and aerospace, industrial, telecom and networking equipment industries, as well as to contract electronic manufacturers.
 
The Company is controlled by Nistec Golan Ltd ("Nistec Golan"). Nistec Golan is controlled indirectly by Mr. Yitzhak Nissan, who owns, indirectly through Nistec Holdings Ltd., all of the shares of Nistec Golan (Nistec Holdings Ltd. and/or any of its subsidiaries are referred to as "Nistec").
 
  b.
Financial covenants:
 
The Company is required to maintain certain financial covenants, including: (i) adjusted shareholders' equity (excluding certain intangible and other assets) equal to the greater of $4.5 million or 17% of its consolidated total assets; and (ii) a debt service ratio of 1.5. Debt service ratio is defined as the ratio of EBITDA to current maturities of long-term debt plus interest expenses. Compliance with the financial covenants is measured annually based on the Company’s annual audited financial statements. As of June 30, 2023 and December 31, 2022, the Company was in compliance with these covenants.
 
  c.
Business risks and condition:
 
The Company’s business is subject to numerous risks including, but not limited to, the impact of currency exchange rates (mainly NIS/US$), the Company's ability to implement its sales and manufacturing plans, the impact of competition from other companies, the Company's ability to receive regulatory clearance or approval to market its products, changes in regulatory environment, domestic and global economic conditions and industry conditions, and compliance with environmental laws and regulations.
 
As of June 30, 2023, the Company's working capital amounted to $14.6 million, and its accumulated deficit amounted to approximately $7.0 million. The Company's liquidity position, as well as its operating performance, may be negatively affected by other financial and business factors, many of which are beyond its control.
v3.23.2
CONSOLIDATED UNAUDITED FINANCIAL STATEMENTS
6 Months Ended
Jun. 30, 2023
Consolidated Unaudited Financial Statements [Abstract]  
CONSOLIDATED UNAUDITED FINANCIAL STATEMENTS
NOTE 2:-
CONSOLIDATED UNAUDITED FINANCIAL STATEMENTS
 
 
The accompanying consolidated unaudited financial statements have been prepared in a condensed format and include the consolidated unaudited financial operations of the Company as of June 30, 2023 and for the six month periods then ended, in accordance with U.S. GAAP, relating to the preparation of financial statements for interim periods.
 
Accordingly, the accompanying consolidated unaudited financial statements do not include all the information and footnotes required by generally accepted accounting principles for a complete set of financial statements. These consolidated unaudited financial statements should be read in conjunction with the audited financial statements and the accompanying notes of the Company for the year ended December 31, 2022 that are included in the Company's Annual Report on Form 20-F, filed with the Securities and Exchange Commission on March 29, 2023 (the "Annual Report"). In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the six months ended June 30, 2023, are not necessarily indicative of the results that may be expected for the year ended December 31, 2023.
v3.23.2
CASH AND CASH EQUIVALENTS
6 Months Ended
Jun. 30, 2023
Cash and Cash Equivalents [Abstract]  
CASH AND CASH EQUIVALENTS
NOTE 3:-
CASH AND CASH EQUIVALENTS
 
   
June 30,
   
December 31,
 
   
2023
   
2022
 
   
Unaudited
       
             
Denominated in U.S. dollars
   
3,235
     
2,334
 
Denominated in NIS
   
3,498
     
2,620
 
Denominated in Euro
   
1,597
     
2,412
 
                 
     
8,330
     
7,366
 
v3.23.2
INVENTORIES
6 Months Ended
Jun. 30, 2023
Inventory, Net [Abstract]  
INVENTORIES
NOTE 4:-
INVENTORIES
   
   
June 30,
   
December 31,
 
   
2023
   
2022
 
   
Unaudited
       
             
Raw materials
   
2,247
     
2,201
 
Work-in-progress
   
2,985
     
2,468
 
Finished goods
   
456
     
461
 
                 
     
5,688
     
5,130
 
 
 
During the periods ended June 30, 2023 and June 30, 2022, the Company recorded inventory write-offs in the amounts of $192 and $126, respectively. Such write-offs were included in cost of revenues.
v3.23.2
COMMITMENTS AND CONTINGENT LIABILITIES
6 Months Ended
Jun. 30, 2023
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENT LIABILITIES
NOTE 5:-
COMMITMENTS AND CONTINGENT LIABILITIES
 
  a.
Pledges:
 
  1.
The Company has pledged certain items of its equipment and the rights to any insurance claims on such items to secure its debts to banks, as well as placed floating liens on all of its remaining assets in favor of the banks.
 
  2.
The Company has also pledged machines to secure its indebtedness to certain suppliers that provided financing for such equipment.
 
  b.
Indemnification agreement:
 
The Company entered into indemnification agreements with each of its directors and officers and undertook to enter into the same agreement with future directors and officers. Such indemnification amount will not exceed: (i) the value of 25% of the Company’s net equity according to the audited or reviewed financial statement known at the time the request for indemnification was submitted; or (ii) $3,000,000, whichever is greater.
     
   
The Israeli Companies Law provides that an Israeli company cannot exculpate an officer holder from liability with respect to a breach of his or her duty of loyalty. If permitted by its articles of association, a company may exculpate in advance an officer from his or her liability to the company, in whole or in part, with respect to a breach of his or her duty of care. However, a company may not exculpate in advance a director from his or her liability to the company with respect to a breach of his duty of care with respect to distributions.
 
The Company's articles of association allow it to exculpate any officer holder from his or her liability for breach of duty of care, to the maximum extent permitted by law, before or after the occurrence giving rise to such liability.
 
  c.
Contingent Liabilities:
 
Environmental Related Matters
 
In March 2019, representatives of the Ministry of Environmental Protection inspected the Company's premises and issued a warning related to an alleged breach of the Clean Air Law and a warning related to the Hazardous Materials Law (1993). On July 18, 2022, the Company received a notification from the Ministry of Environmental Protection about its intention to impose a penalty of approximately $0.1 million for an alleged breach of the Hazardous Materials Law (1993). The Company paid the penalty during 2023.
 
In January 2023, the Company received a notification from the Ministry of Environmental Protection about its intention to impose a penalty of approximately $0.6 million for an alleged breach of the Clean Air Law during the years 2019-2020. The Company has filed a request to reduce the amount of the penalty in accordance with the provisions of the Clean Air Law. In August 2023, the Ministry of Environmental Protection notified the Company that it has rejected the Company's request. The Company recorded a provision in the total amount of the penalty. The Company is considering filing an administrative appeal in regard to the Ministry of Environmental Protection decision.
 
   
Employee related matters
 
In May 2008, June 2019 and November 2019, lawsuits were filed by three employees alleging that they had suffered personal injuries during their employment and they are seeking aggregate financial compensation of approximately $ 121 for past damages and additional amounts for future lost income, pain and suffering as the court may determine.
 
In January 2011 and December 2019, five additional employees notified the Company that they allegedly suffered personal injuries during their employment with the Company. Of these five employees, two are seeking compensation of $1.7 million and the others did not state their claim amount.
 
The above-mentioned claims were submitted to the Company’s insurance company, which informed the Company that it is reviewing the statements of claim without prejudicing its rights to deny coverage.
 
During the period February 2019 through October 2020, two former employees filed lawsuits seeking additional payments in connection with their employment with the Company and subsequent termination. The aggregate amount claimed in the two lawsuits is approximately $345. The Company recorded a provision according to its legal advisor's opinion.
v3.23.2
SHAREHOLDERS' EQUITY
6 Months Ended
Jun. 30, 2023
Stockholders' Equity Attributable to Parent [Abstract]  
SHAREHOLDERS' EQUITY
NOTE 6:-
SHAREHOLDERS' EQUITY
 
   
Stock Option Plan:
 
The Company’s 2018 Share Incentive Plan (the "Plan") authorizes the grant of options to purchase shares and restricted shares units (“RSUs”) to officers, employees, directors and consultants of the Company and its subsidiaries. Awards granted under the Plan to participants in various jurisdictions may be subject to specific terms and conditions for such grants as may be approved by the Company’s board from time to time.
 
Each option granted under the Plan is exercisable for a period of ten years from the date of the grant of the option or the expiration dates of the option plan. The options primarily vest gradually over four years of employment.
 
As of June 30, 2023 options to purchase 337,134 ordinary shares were outstanding under the Plan, exercisable at an average exercise price of $5.07 per share. The share-based compensation expense related to employees' equity-based awards, recognized during the six months ended June 30, 2023 and 2022 was $144 and $117, respectively
     
   
A summary of employee option activity under the Plan as of June 30, 2023 and changes during the six months period ended June 30, 2023 are as follows:
 
   
Number of
options
   
Weighted-average exercise
price
   
Weighted- average remaining contractual life
(in months)
   
Aggregate intrinsic
value
(in thousands)
 
                         
Outstanding at January 1, 2023
   
395,171
     
5.25
     
95
     
1
 
Exercised
   
58,037
     
5.15
     
-
     
-
 
Forfeited
   
-
     
-
     
-
     
-
 
                                 
Outstanding at June 30, 2023
   
337,134
     
5.07
     
91
     
1,442
 
                                 
Exercisable at June 30, 2023
   
193,046
     
4.90
     
86
     
859
 
 
   
The aggregate intrinsic value in the table above represents the total intrinsic value (the difference between the Company's closing share price on the last trading day of the second quarter of fiscal 2023 and the exercise price, multiplied by the number of in-the-money options). This amount changes based on the fair market value of the Company's share. As of June 30, 2023, there was approximately $527 of unrecognized compensation costs related to non-vested share-based compensation arrangements granted under the Company's share option plans. This cost is expected to be recognized over a period of up to 4 years.
v3.23.2
ENTITY WIDE DISCLOSURES
6 Months Ended
Jun. 30, 2023
Segment Reporting [Abstract]  
ENTITY WIDE DISCLOSURES
NOTE 7:-
ENTITY WIDE DISCLOSURES
 
  a.
Customers who accounted for over 10% of the total consolidated revenues:
 
   
Six months ended
June 30,
   
Three months ended
June 30,
 
   
2023
   
2022
   
2023
   
2022
 
   
Unaudited
 
                         
Customer A - sales of manufactured products
   
14.4
%
   
20.2
%
   
13.5
%
   
17.9
%
Customer B - Sales of manufactured products
   
11.0
%
   
9.8
%
   
11.9
%
   
9.3
%
 
  b.
Revenues by geographic areas:
 
   
Six months ended
June 30,
   
Three months ended
June 30,
 
   
2023
   
2022
   
2023
   
2022
 
   
Unaudited
 
                         
Israel
   
11,548
     
10,808
     
6,332
     
5,314
 
North America
   
2,911
     
3,708
     
1,826
     
1,773
 
 Netherlands
   
2,884
     
1,402
     
1,187
     
618
 
India
   
3,222
     
1,366
     
908
     
752
 
Others
   
1,948
     
1,560
     
790
     
632
 
                                 
     
22,513
     
18,844
     
11,043
     
9,089
 
v3.23.2
TAXES ON INCOME
6 Months Ended
Jun. 30, 2023
Income Tax Disclosure [Abstract]  
TAXES ON INCOME
NOTE 8:-
TAXES ON INCOME
 
  a.
Deferred tax assets and liabilities:
 
The Company has net operating loss carryforwards for tax purposes of approximately $10.4 million, which may be carried forward indefinitely for which deferred tax assets was created.
 
  b.
Reconciliation of the theoretical income tax expense to the actual income tax expense:
 
For the six months period ended June 30, 2023 and 2022 the main differences between the theoretical tax expenses (statutory tax rate of 23%) and the actual tax expenses are tax benefit arising from "Preferred enterprises" and non-deductible items and others.
v3.23.2
RELATED PARTY BALANCES AND TRANSACTIONS
6 Months Ended
Jun. 30, 2023
Related Party Transactions [Abstract]  
RELATED PARTY BALANCES AND TRANSACTIONS
NOTE 9:-
RELATED PARTY BALANCES AND TRANSACTIONS
 
 
Nistec, the controlling shareholder of the Company, is also a customer of the Company. The Company sells products to Nistec, pays management fees to Nistec, purchases certain services from Nistec and shares certain expenses with Nistec, for services that it acquires jointly with Nistec. The Company's transactions with Nistec were carried out on an arm's-length basis.
 
  a.
Balances with related parties:
 
   
Six months ended
June 30,
   
Year ended
December 31,
 
   
2023
   
2022
 
   
Unaudited
       
             
Trade accounts receivable
   
190
     
151
 
Trade accounts payable
   
277
     
30
 
 
  b.
Transactions with related parties:
 
   
Six months ended
June 30,
   
Three months ended
June 30,
 
   
2023
   
2022
   
2023
   
2022
 
   
Unaudited
 
                         
Revenues
   
419
     
260
     
182
     
82
 
Purchases, selling, general and administrative expenses
   
365
     
263
     
288
     
78
 
 
   
PCB purchases by Nistec - Nistec purchases PCBs from the Company solely to provide assembled boards to its customers. The Company sells to Nistec based on its standard pricing, which may be subject to a discount of up to ten percent (10%). Should the order be for PCBs imported by the Company, the quote reflects the actual price of such PCBs, plus a mark-up of at least twenty percent (20%). Should the order be for PCBs from excess inventory of an original order, the quote will reflect the standard price of such PCBs, with a discount of up to fifty percent (50%) of the price actually paid for such PCBs in the original order (the “Excess Inventory Discount”). The Excess Inventory Discount will apply only to orders from excess inventory of the first original order of a specific PCB (i.e., should a second order of a specific PCBs generate any excess inventory, and Nistec would like to purchase such excess, the Excess Inventory Discount will not be applied to such purchase).
 
Soldering and assembly services - The Company may acquire soldering services and/or purchase services from Nistec. Nistec’s pricing for its soldering services will be its standard pricing (the “Pricing”), less a five percent (5%) discount. Nistec may charge for Purchasing Services in accordance with the actual costs of the orders, plus a fourteen and a quarter (14.25%) commission, which reflects a five percent (5%) discount, as compared to the commission charged to third parties by Nistec for similar services. Prices of services not included in the Pricing will be negotiated by the parties in good faith (without participation of Mr. Nissan, the Company's controlling shareholder and CEO, or any of his relatives). Nistec standard procedures govern manufacturer warranties and restrictions regarding defective assembled products. In addition to requesting Nistec to provide the Company with a quote for soldering and assembly services, in the event that the Company requires design and/or design services for production of PCBs, it may ask Nistec to provide it with a quote for such services. Nistec may charge for design and/or design services in accordance with its standard pricing for such services, less a five percent (5%) discount. The Company’s purchases of services under the Soldering, Assembly and Design Services Procedure may not exceed NIS 300 per annum.
 
Managements fees - In September 2019, the Company's Audit Committee, Compensation Committee and Board of Directors, as applicable, approved the terms of the amended Management Agreement. This amended Management Agreement was approved by the Company's shareholders in the annual general meeting, held on December 5, 2019. Nistec is entitled to a monthly management fee of NIS 90 ($28).
 
Subject to Company’s reimbursement policy approved by the Audit Committee on May 15, 2016, Mr. Nissan receives reimbursement of travel expenses (other than food and beverage expenses) while traveling internationally on behalf of the Company, provided that such reimbursement will not exceed an aggregate amount of NIS 10,000 ($2,700) per calendar quarter. Mr. Nissan is reimbursed for food and beverage expenses while traveling internationally on behalf of the Company, against receipts, in accordance with the Israeli Income Tax Regulations (Deduction of Certain Expenses) 1972.
     
   
In addition, the Company's shareholders in the annual general meetings held on December 5, 2019, October 29, 2020 and August 31, 2022 approved the following:
 
  a.
The extension of the Directors and Officers Indemnity Agreement with Mr. Yitzhak Nissan.
  b.
The extension of the Exculpation Letter for an additional three (3) year period
  c.
The application of the Company’s directors and officers' liability insurance policy with respect to Mr. Yitzhak Nissan
  d.
The revised terms of employment of Yitzhak Nissan's daughter who is employed by the Company as a special project manager.
v3.23.2
SUBSEQUENT EVENTS
6 Months Ended
Jun. 30, 2023
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS
NOTE 10:-
SUBSEQUENT EVENTS
 
   
Subsequent to the balance sheet date, the Company's Board of Directors approved the grant of 117,000 options to officers and employees of the Company. The options are in accordance with the Company's 2018 plan and have an exercise price of $9.11 per share. 33,000 options are subjected to the approval of shareholders at our Annual General Meeting to be held during September 2023.
 
In addition, the Board has approved grants of 10,000 options to each of its five Board members. The grants will be effective as of October 6, 2023, and are subject to the approval of shareholders at our Annual General Meeting to be held during September 2023. The exercise price will be determined based on the average price of the Company's shares during the 30-day period prior to October 6, 2023. The options are in accordance with the Company's 2018 option plan.

 

v3.23.2
CASH AND CASH EQUIVALENTS (Tables)
6 Months Ended
Jun. 30, 2023
Cash and Cash Equivalents [Abstract]  
Schedule Of Cash and Cash Equivalents
   
June 30,
   
December 31,
 
   
2023
   
2022
 
   
Unaudited
       
             
Denominated in U.S. dollars
   
3,235
     
2,334
 
Denominated in NIS
   
3,498
     
2,620
 
Denominated in Euro
   
1,597
     
2,412
 
                 
     
8,330
     
7,366
 
v3.23.2
INVENTORIES (Tables)
6 Months Ended
Jun. 30, 2023
Inventory, Net [Abstract]  
Schedule Of Inventories
   
June 30,
   
December 31,
 
   
2023
   
2022
 
   
Unaudited
       
             
Raw materials
   
2,247
     
2,201
 
Work-in-progress
   
2,985
     
2,468
 
Finished goods
   
456
     
461
 
                 
     
5,688
     
5,130
 
v3.23.2
SHAREHOLDERS' EQUITY (Tables)
6 Months Ended
Jun. 30, 2023
Stockholders' Equity Attributable to Parent [Abstract]  
Schedule of Employee Option Activity
   
Number of
options
   
Weighted-average exercise
price
   
Weighted- average remaining contractual life
(in months)
   
Aggregate intrinsic
value
(in thousands)
 
                         
Outstanding at January 1, 2023
   
395,171
     
5.25
     
95
     
1
 
Exercised
   
58,037
     
5.15
     
-
     
-
 
Forfeited
   
-
     
-
     
-
     
-
 
                                 
Outstanding at June 30, 2023
   
337,134
     
5.07
     
91
     
1,442
 
                                 
Exercisable at June 30, 2023
   
193,046
     
4.90
     
86
     
859
 
v3.23.2
ENTITY WIDE DISCLOSURES (Tables)
6 Months Ended
Jun. 30, 2023
Segment Reporting [Abstract]  
Schedule of Customers Who Accounted For Over 10% Of The Total Consolidated Revenues
 
   
Six months ended
June 30,
   
Three months ended
June 30,
 
   
2023
   
2022
   
2023
   
2022
 
   
Unaudited
 
                         
Customer A - sales of manufactured products
   
14.4
%
   
20.2
%
   
13.5
%
   
17.9
%
Customer B - Sales of manufactured products
   
11.0
%
   
9.8
%
   
11.9
%
   
9.3
%
Schedule Of Revenues By Geographic Areas
 
   
Six months ended
June 30,
   
Three months ended
June 30,
 
   
2023
   
2022
   
2023
   
2022
 
   
Unaudited
 
                         
Israel
   
11,548
     
10,808
     
6,332
     
5,314
 
North America
   
2,911
     
3,708
     
1,826
     
1,773
 
 Netherlands
   
2,884
     
1,402
     
1,187
     
618
 
India
   
3,222
     
1,366
     
908
     
752
 
Others
   
1,948
     
1,560
     
790
     
632
 
                                 
     
22,513
     
18,844
     
11,043
     
9,089
 
v3.23.2
RELATED PARTY BALANCES AND TRANSACTIONS (Tables)
6 Months Ended
Jun. 30, 2023
Related Party Transactions [Abstract]  
Schedule of Related Party Balances And Transactions
  a.
Balances with related parties:
 
   
Six months ended
June 30,
   
Year ended
December 31,
 
   
2023
   
2022
 
   
Unaudited
       
             
Trade accounts receivable
   
190
     
151
 
Trade accounts payable
   
277
     
30
 
 
  b.
Transactions with related parties:
 
   
Six months ended
June 30,
   
Three months ended
June 30,
 
   
2023
   
2022
   
2023
   
2022
 
   
Unaudited
 
                         
Revenues
   
419
     
260
     
182
     
82
 
Purchases, selling, general and administrative expenses
   
365
     
263
     
288
     
78
 
v3.23.2
DESCRIPTION OF BUSINESS AND GENERAL (Narrative) (Details)
$ in Thousands
6 Months Ended
Jun. 30, 2023
USD ($)
Dec. 31, 2022
USD ($)
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Minimum shareholder's equity to be maintained under debt covenants $ 4,500  
Ratio of shareholders' equity to total assets required to be maintained under debt covenants 17.00%  
Debt service ratio required to be maintained under debt covenants 1.5  
Working capital $ 14,600  
Accumulated deficit $ (6,998) $ (9,873)
v3.23.2
CASH AND CASH EQUIVALENTS (Schedule of Cash and Cash Equivalents) (Details) - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Cash and Cash Equivalents [Line Items]    
Cash $ 8,330 $ 7,366
Denominated in U.S. dollars [Member]    
Cash and Cash Equivalents [Line Items]    
Cash 3,235 2,334
Denominated in NIS [Member]    
Cash and Cash Equivalents [Line Items]    
Cash 3,498 2,620
Denominated in Euro [Member]    
Cash and Cash Equivalents [Line Items]    
Cash $ 1,597 $ 2,412
v3.23.2
INVENTORIES (Schedule of Inventories) (Details) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Inventory, Net [Abstract]      
Raw materials $ 2,247   $ 2,201
Work-in-progress 2,985   2,468
Finished goods 456   461
Total inventories 5,688   $ 5,130
Inventory write-offs $ 192 $ 126  
v3.23.2
COMMITMENTS AND CONTINGENT LIABILITIES (Narrative) (Details)
1 Months Ended 6 Months Ended 21 Months Ended
Jan. 31, 2023
USD ($)
Jul. 18, 2022
USD ($)
Jun. 30, 2023
USD ($)
Oct. 31, 2020
USD ($)
Former_Employees
Indemnification agreement limit as a percentage of shareholders' equity     25.00%  
Amount of net equity of indemnification     $ 3,000,000  
Number of former employees filing lawsuits | Former_Employees       2
Financial compensation sought for past damages plus additional amounts for future lost income and pain and suffering     121,000 $ 345,000
Penalty amount $ 600,000 $ 100,000    
Other Employees [Member]        
Financial compensation sought for past damages plus additional amounts for future lost income and pain and suffering     $ 1,700,000  
v3.23.2
SHAREHOLDERS' EQUITY (Narrative) (Details) - USD ($)
$ / shares in Units, $ in Thousands
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Options exercised 58,037  
Share-based compensation $ 144 $ 117
Unrecognized compensation costs $ 527  
Unrecognized compensation costs, period 4 years  
Share Incentive Plan 2018 [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Exercisable period 10 years  
Share Incentive Plan 2019 [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Options exercised 337,134  
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price $ 5.07  
v3.23.2
SHAREHOLDERS' EQUITY (Schedule of Employee Option Activity) (Details)
$ / shares in Units, $ in Thousands
6 Months Ended 12 Months Ended
Jun. 30, 2023
USD ($)
$ / shares
shares
Dec. 31, 2022
USD ($)
$ / shares
shares
Number of options    
Outstanding at January 1, 2023 | shares 395,171  
Exercised | shares 58,037  
Forfeited | shares 0  
Outstanding at June 30, 2023 | shares 337,134 395,171
Exercisable at June 30, 2023 | shares 193,046  
Weighted-average exercise price    
Outstanding at January 1, 2023 | $ / shares $ 5.25  
Exercised | $ / shares 5.15  
Forfeited | $ / shares 0  
Outstanding at June 30, 2023 | $ / shares 5.07 $ 5.25
Exercisable at June 30, 2023 | $ / shares $ 4.9  
Weighted- average remaining contractual life (in months)    
Outstanding 91 months 95 months
Exercisable at June 30, 2023 86 months  
Aggregate intrinsic value    
Outstanding | $ $ 1,442 $ 1
Exercisable at June 30, 2023 | $ $ 859  
v3.23.2
ENTITY WIDE DISCLOSURES (Schedule of Customers who Accounted For Over 10% of Total Consolidated Revenues) (Details) - Revenue [Member] - Customer Concentration Risk [Member]
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Customer A [Member]        
Product Information [Line Items]        
Sales of manufactured products 13.50% 17.90% 14.40% 20.20%
Customer B [Member]        
Product Information [Line Items]        
Sales of manufactured products 11.90% 9.30% 11.00% 9.80%
v3.23.2
ENTITY WIDE DISCLOSURES (Schedule of Revenues by Geographic Areas) (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Segment Reporting Information [Line Items]        
Revenues $ 11,043 $ 9,089 $ 22,513 $ 18,844
Israel [Member]        
Segment Reporting Information [Line Items]        
Revenues 6,332 5,314 11,548 10,808
North America [Member]        
Segment Reporting Information [Line Items]        
Revenues 1,826 1,773 2,911 3,708
Netherlands [Member]        
Segment Reporting Information [Line Items]        
Revenues 1,187 618 2,884 1,402
India [Member]        
Segment Reporting Information [Line Items]        
Revenues 908 752 3,222 1,366
Others [Member]        
Segment Reporting Information [Line Items]        
Revenues $ 790 $ 632 $ 1,948 $ 1,560
v3.23.2
TAXES ON INCOME (Narrative) (Details) - USD ($)
$ in Millions
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Income Tax Disclosure [Abstract]    
Net operating loss carryforward $ 10.4  
Statutory tax rates 23.00% 23.00%
v3.23.2
RELATED PARTY BALANCES AND TRANSACTIONS (Narrative) (Details) - Nistec [Member]
₪ in Thousands, $ in Thousands
6 Months Ended
Jun. 30, 2023
ILS (₪)
Jun. 30, 2023
USD ($)
Related Party Transaction [Line Items]    
Related Party Transaction Discount Rate On Purchases 10.00% 10.00%
Percentage of mark up related to actual price of purchase 20.00% 20.00%
Percentage of discount on excess inventory 50.00% 50.00%
Percentage of standard discount 5.00% 5.00%
Percentage of commission 14.25% 14.25%
Total purchases ₪ 300  
Reimbursement expense 10,000 $ 2,700
Management Fee Expense ₪ 90 $ 28
v3.23.2
RELATED PARTY BALANCES AND TRANSACTIONS (Schedule of Transactions/Balances with related parties) (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Related Party Transactions [Abstract]          
Trade accounts receivable $ 190   $ 190   $ 151
Trade accounts payable 277   277   $ 30
Revenues 182 $ 82 419 $ 260  
Purchases, selling, general and administrative expenses $ 288 $ 78 $ 365 $ 263  
v3.23.2
SUBSEQUENT EVENTS (Narrative) (Details) - Subsequent Event [Member] - $ / shares
1 Months Ended
Oct. 06, 2023
Jul. 31, 2023
Sep. 30, 2023
Officers and Employees [Member]      
Subsequent Event [Line Items]      
Number of option granted   117,000  
Exercise price per share   $ 9.11  
Options are subjected to approval     33,000
Five Board Members [Member]      
Subsequent Event [Line Items]      
Number of option granted 10,000    

Eltek (NASDAQ:ELTK)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more Eltek Charts.
Eltek (NASDAQ:ELTK)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more Eltek Charts.